Shaker Dakhil, MD
Basic profileShaker Dakhil is an Oncology physician affiliated with Cancer Center of Kansas. OpenAlex indexes 427 publications with 37,397 citations (h-index 81). By OpenAlex citation count, this profile ranks in the top 5% of Hematology / Oncology profiles in the FindMyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingIndustry payments
113 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- NovartisProgram year20259 paymentsResearch$1,243,392
- AmgenProgram year20253 paymentsResearch$137,571
- BeiGeneProgram year202511 paymentsResearch$38,240
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward. Research funding is listed under each investigator the record names.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
39.9%PD-1 inhibitor18.8%Pembrolizumab55%Nivolumab45%Part B, office-administered≥40 patientsPlatinum-based Drug6.3%Oxaliplatin97%Carboplatin3%Part B, office-administered≥43 patients+ 15 more classes in this area
Blood & clotting
28.1%Iron, parenteral preparations20.8%Ferric carboxymaltose100%Part B, office-administered≥41 patientsErythropoiesis-stimulating Agent7.3%Darbepoetin alfa58%Epoetin alfa42%Part B, office-administered≥26 patientsMetabolism & gastrointestinal
17.1%Substance P/Neurokinin-1 Receptor Antagonist9.5%Aprepitant100%Part B, office-administered≥103 patientsSerotonin-3 Receptor Antagonist7.1%Granisetron82%Ondansetron hydrochloride14%Palonosetron hcl4%Ondansetron Hcl0%Ondansetron Odt0%Part D + Part B≥84 patients+ 4 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2001–2018 per NIH RePORTER. The latest:
- National Community Oncology Research Project
Via Christi Regional Medical Center
FY2018$1,527,000UG1CA189808 - National Community Oncology Research Project
Via Christi Regional Medical Center
FY2017$1,835,874UG1CA189808 - National Community Oncology Research Project
Via Christi Regional Medical Center
FY2016$1,612,500UG1CA189808
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Bassam Mattar, MD
Cancer Center of Kansas
Christopher Dakhil, MD
Cancer Center of Kansas
Jeremy Deutsch, MD
Cancer Center of Kansas
Dennis Moore, MD
Cancer Center of Kansas
Carl June, MD
University of Pennsylvania
Stuart Orkin, MD
Harvard Medical School
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”